Every year, an estimated 20 million people worldwide sustain a concussion or other traumatic brain injury (TBI), which leads to a two- to fourfold increase in the risk of depression, anxiety and post-traumatic stress disorder (PTSD). Yet not everyone who experiences a TBI goes on to develop psychiatric symptoms.
Blood Protein May Reduce Depression and PTSD Risk After Traumatic Brain Injury
A study indicates that a specific blood protein may reduce the risk of depression and PTSD in individuals who have suffered a traumatic brain injury (TBI). This research is significant as it addresses mental health issues that can affect a large population, including those in Iran. Understanding these links could improve mental health outcomes in the country.
👥 Key Players
📰 What Happened
A study has found that a specific blood protein may help reduce the risk of depression and PTSD in individuals who have experienced traumatic brain injuries. This research highlights the potential for biological interventions in mental health care.
- Approximately 20 million people worldwide suffer from TBIs each year.
- Not all individuals with TBIs develop psychiatric conditions, indicating a need for targeted interventions.
💡 Why It Matters
📚 Background
Traumatic brain injuries are a major public health issue, often leading to long-term psychological effects. Understanding biological factors can lead to better preventive and therapeutic strategies.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%